Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarpogrelate SR in type 2 diabetic peripheral vascular disease
KCT0005088Phase 4Recruiting
- Sponsor
- Daewoong Pharmaceutical
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sarpogrelate in peripheral artery occlusion (PAD), type 2 diabetes mellitus (T2DM), sponsored by Daewoong Pharmaceutical. Started Jun 2021; status: recruiting.
02
Drugs
sarpogrelate
03
Conditions
peripheral artery occlusion (PAD)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on KCT0005088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0005088.